Skip to content
10-K

Annual Report

Boundless Bio, Inc. BOLD

0000950170-25-045725

← back to feed
Filed
Mar 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 21, 2025 22.3M sh
Shares Diluted FY 2024 · Dec 31, 2023 1.22M sh
Capex FY 2024 · Dec 31, 2023 $633K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$46.86M
Short Term Investments FY 2024 · Dec 31, 2023 $97.05M
Cash And Equivalents FY 2024 · Dec 31, 2023 $23.71M
Stockholders Equity FY 2024 · Dec 31, 2023 −$127.08M
Current Liabilities FY 2024 · Dec 31, 2023 $9.36M
Total Liabilities FY 2024 · Dec 31, 2023 $9.36M
Current Assets FY 2024 · Dec 31, 2023 $124.2M
Total Assets FY 2024 · Dec 31, 2023 $129.89M
Eps Diluted FY 2024 · Dec 31, 2023 −$40.65
Eps Basic FY 2024 · Dec 31, 2023 −$40.65
Sga Expense FY 2024 · Dec 31, 2023 $12.16M
Rd Expense FY 2024 · Dec 31, 2023 $42.64M
Net Income FY 2024 · Dec 31, 2023 −$49.43M
Operating Income FY 2024 · Dec 31, 2023 −$54.8M